Ameriprise Financial Inc Cidara Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.87 - $2.7 $36,034 - $52,029	-19,270 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.06 - $3.01 $39,696 - $58,002	19,270 New	19,270 $51,000
Q1 2020 May 15, 2020	SELL	$1.74 - $4.26 $21,114 - $51,695	-12,135 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.77 - $3.84 $21,478 - $46,598	12,135 New	12,135 $47,000
Q1 2019 May 15, 2019	SELL	$2.35 - $3.27 $28,138 - $39,154	-11,974 Closed	0 $0

Q3 2017 Nov 07, 2017	BUY	$5.75 - $8.1 $68,850 - $96,989	11,974	11,974 $97,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $837M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.